Seminar 2017 Full Session Schedule
Share |

CSHP has an amazing array of courses to be offered at Seminar 2017! Below you may view our full schedule of sessions planned for Seminar 2017. You may also view our session on a daily perspective. Please note that all session information are subject to change.

Want to view the Conference Schedule? Click here!

These activities are eligible for ACPE credit; see final CPE activity announcement for specific details.
Last Updated: 10/17/2017

DAILY SESSION SCHEDULES
Thursday
Friday Saturday Sunday

 

 

FULL SESSION SCHEDULE
- Seminar 2017 Sessions - Thursday, October 26, 2017 -


Thursday, October 26 | 8:00am - 5:00pm (prior registration required)

Advanced Practice Pharmacist Certificate Program - Chronic Disease State Management

Course Description: This program. developed in partnership with Touro University School of Pharmacy, will focus on management of common chronic disease states and issues including hypertension, diabetes, hyperlipidemia, anticoagulation, depression, anxiety, and safe medication use in older adults.
Learning Objectives:
  1. Performing patient assessments.
  2. Ordering and interpreting drug therapy-related tests.
  3. Referring patients to other health care providers.
  4. Participating in the evaluation and management of disease and health conditions in collaboration with other health care providers.
  5. Initiating, adjusting and discontinuing drug therapy
Track: Certificate Program
Registration: Click here

Thursday, October 26 | 8:00am - 5:00pm (prior registration required)

Pharmacogenomics Certificate Program

Course Description: This program has been designed specifically for health-system pharmacists to provide them with the knowledge of genetic factors that influence drug disposition, response, and adverse effects. Program participants will gain the practical, clinical skills necessary to apply precision medicine at their own practice settings.
Track: Certificate Program
Registration: Click here

Thursday, October 26 | 8:00am - 3:00pm (prior registration required)

Transitions of Care Certificate Program

Course Description: This program is designed to provide the participant with a comprehensive approach to developing a transitions of care program in their own practice setting through web-based modules and a live interactive session at the CSHP Seminar Conference.

The web-based self-study modules will provide evidence-based literature demonstrating the impact of pharmacy staff transitions of care on patient care and a stepwise approach to creation and expansion of transitions of care services integrating technicians, pharmacy students and residents. Modules are designed to be sequential and build upon the information presented in the previous session. The series also follows a patient from hospital admission through to discharge and post-discharge, and including the pharmacy staff’s roles and responsibilities at each phase of care. Metrics to demonstrate the impact of transitions of care will also be provided.
Track: Certificate Program
Registration: Click here

Thursday, October 26 | 1:00pm - 2:00pm

New Insulin Agents and Their Role in the Treatment of Type 2 Diabetes

Course Description: A discussion of recently FDA approved and pipeline insulin products.
Learning Objectives:
  1. Differentiate between the newly FDA approved insulins in diabetes management.
  2. Identify investigational insulin products in the pipeline.
  3. Summarize pivotal clinical trials relating to these products.
  4. Describe the role of insulin products used in the treatment of patients with type 2 diabetes based on current clinical guidelines.
Track: Breaking News
Content Level: Level 2: Working Knowledge
Speaker: Natalie Aboubechara, PharmD, BCPS
                     Pharmacist Evidence Analyst and Strategist | Kaiser Permanente

Thursday, October 26 | 1:00pm - 2:00pm

Updates in Anticoagulation in Oncology Patients

Course Description: The most recent CHEST guidelines for VTE were published in February 2016 and continue to recommend LMWH therapy over VKA or any direct acting oral coagulant (DOACs). Despite being preferred in the VTE guidelines, there are several drawbacks to LMWH. The newer DOACs are now suggested over VKA therapy for DVT or PE in certain patients without cancer, yet there is a paucity of data to support the efficacy (or lack of efficacy) in patients with cancer. It is often difficult to adhere to the guidelines’“one-size-fits-all” preference for LMWH in cancer. Therefore the purpose of this educational talk is to provide an evaluation and summary of the available literature regarding anticoagulation in cancer patients so that pharmacists can determine the best course of therapy for their patients.
Learning Objectives:
  1. Explain how patients with cancer are at increased risk for developing VTE.
  2. Summarize recommendations from the major guidelines for pharmacological management of VTE in patients with cancer
  3. Discuss the pros and cons of low molecular weight heparin in patients with cancer
  4. Summarize the available data associated with direct acting oral anticoagulants in the treatment of VTE in patients with cancer.
Track: Therapy Management
Content Level: Level 2: Working Knowledge
Speaker: Bao Dao, PharmD, MBA, BCPS, BCOP
                     Hematology/Bone Marrow Transplant Clinical Pharmacist | UCSF Medical Center

Thursday, October 26 | 2:15pm - 3:15pm

New Developments in Cardiology

Course Description: Recent papers that have been published in the field of cardiology will be discussed.
Learning Objectives:
  1. Discuss the papers that have been published in the past year in the field of cardiology.
  2. Apply the findings of recent cardiology studies to clinical practice.
Track: Cardiovascular
Content Level: Level 2: Working Knowledge
Speaker: Javad Trafreshi, Pharm.D., BCPS-AQ Cardiology, F.A.H.A.
                     Professor, Chair, and Director | Loma Linda University School of Pharmacy

Thursday, October 26 | 2:15pm - 3:15pm

340B: Are You Audit Ready?

Course Description: As external auditors for 340B programs, we will provide insider's knowledge and updates for today's 340B HRSA audits. Also, tips for overlooked hospital savings and procurement opportunities will be discussed.
Learning Objectives:
  1. Describe the HRSA 340B audit process with the major areas of focus for the audit.
  2. Name the key components of an internal audit process.
  3. Describe the process of a corrective action plan.
  4. List areas of business opportunity for the expansion of your 340B program.
Track: Practice Management
Content Level: Level 2: Working Knowledge
Co-Speaker: Suzanne B. Shea, BS Pharmacy, MBA
                              Senior Consultant | Comprehensive Pharmacy Services
Co-Speaker: Bruce Thompson, RPh, MS
                              Division VP -Compliance and Regulatory Consulting | Comprehensive Pharmacy Services

Thursday, October 26 | 3:30pm - 4:30pm

Honing Your Presentation Skills

Course Description: This program is designed to improve the presentation skills of junior faculty, residents, fellows, students, or any clinicians who are required to present as part of their jobs or training.
Learning Objectives:
  1. Identify strategies to become a more effective speaker.
  2. List activities to avoid during a speaking engagement.
Track: Practice Management
Content Level: Level 2: Working Knowledge
Speaker: Javad Trafreshi, Pharm.D., BCPS-AQ Cardiology, F.A.H.A.
                     Professor, Chair, and Director | Loma Linda University 

Thursday, October 26 | 3:30pm - 4:30pm

Rally the Troops: Practical Strategies for Developing a Medication Safety Team

Course Description: This presentation will describe how to develop a collaborative team to support improving the safety of medication use processes and preventing errors that could lead to harm.
Pharmacist Objectives:
  1. Identify individuals who can assist in medication safety activities.
  2. Describe methods of teaching medication safety principles to your team.
  3. Explain the value of developing a team to work on medication safety related initiatives.
Technician Objectives:
  1. Identify individuals who can assist in medication safety activities.
  2. Describe methods of teaching medication safety principles to your team.
  3. Explain the value of developing a team to work on medication safety related initiatives.
Track: Practice Managementshifting the 
Content Level: Level 2: Working Knowledge
Speaker: Katayoon Kathy Ghomeshi, PharmD, MBA, BCPS
                     Medication Safety Specialist | UCSF Medical Center

Thursday, October 26 | 4:45pm - 5:45pm

Teaching the Pharmacists' Patient Care Process: A Guide for Preceptors

Course Description: This course will discuss the purpose and components of the recently developed Pharmacists' Patient Care Process (PPCP) and provide strategies on how to incorporate PPCP into experiential education.
Learning Objectives:
  1. Describe the purpose and individual components of the Pharmacists' Patient Care Process (PPCP).
  2. Describe the implications of the PPCP on the curricular and postgraduate requirements.
  3. Incorporate PPCP into experiential activities for students.
Track: Preceptor Development
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Marie Scott, PharmD
                              Assistant Clinical Professor/Regional Coordinator | University of the Pacific
Co-Speaker: Jenana H Maker, PharmD, BCPS
                              Associate Professor | Comprehensive Pharmacy Services

Thursday, October 26 | 4:45pm - 5:45pm

From Volume to Value: Changing the Way We Pay For Health Care

Course Description: Over the past decade, health care payment in the U.S. has begun shifting from a fee-for-service model toward one in which value and performance are rewarded. This shift has been catalyzed by the Affordable Care Act and further reinforced by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), which increased the emphasis on payment for delivery of quality care by physicians and other clinicians. Today, value-based payment is a priority strategy for improving health care quality and patient outcomes while managing costs.

It is no surprise that the shift in payment models has expanded into the practice of pharmaceutical contracting. Value-based contracts (VBCs) between manufacturers and payers or other risk-bearing entities are gaining popularity as a method for paying based on the value the treatment delivers. The move to value-based payment is not without challenges, however, and many barriers exist to its implementation. This session will explore the shift from volume- to value-based payment in health care, provide examples of models currently being implemented, summarize value frameworks being used to assess treatment value, and provide insight into how challenges to this evolution can be overcome. Insights from the AMCP Partnership Forum on Value-based Contracting will be shared.
Learning Objectives:
  1. Describe the rationale and drivers of the current shift toward payment based on value rather than volume.
  2. Summarize new and emerging models in value-based payment, including outcomes-based contracting and the role of quality measures.
  3. Discuss and debate the current challenges to value-based payment, including regulatory barriers, and propose possible solutions
Track: Practice Management
Content Level: Level 2: Working Knowledge
Speaker: Susan A. Cantrell, RpH, CAE
                     Chief Executive Officer | Academy of Managed Care Pharmacy

- Seminar 2017 Sessions - Friday, October 27, 2017 -


Friday, October 27 | 8:00am - 9:30am

CV Workshop 

Course Description: This presentation will review the singular purpose of a CV, how to format the responsibilities section, how to write accomplishments, and the three most important residency interview selection criteria.
Learning Objectives:
  • CV's that have been submitted prior to Seminar will also be individually reviewed.
Track: Student Programming
Content Level: Level 1: No Prior Knowledge
Speaker:
 Rodney Gedey, PharmD, BCPS
                Director, Drug Information Services | Envolve Pharmacy Solutions 

Friday, October 27 | 8:30am - 9:30am

Trending Now #New Drugs - Part 1 

Course Description: Information pertinent to new drug approvals from the last year will be discussed for incorporation into current practice.
Pharmacist Objectives:
  1. Describe selected new drug approvals and trends at the Food and Drug Administration (FDA) from July 2016 through July 2017.
  2. Identify the first checkpoint inhibitor approved for Merkel cell carcinoma.
  3. Describe the indication and dosing for first-in-class human monoclonal antibody approved for C.difficile.
Technician Objectives:
  1. List four or more new drug approvals by the FDA from July 2016 to July 2017.
  2. Name at least three new drugs approved for cancer indications.
  3. Name the first approved drug for spinal muscular dystrophy.
Track: Breaking News
Content Level: Level 1: No Prior Knowledge
Co-Speaker:
Timothy Chiu, PharmD, BCPS
                              Pharmacist Evidence Analyst & Strategist | Kaiser Permanente
Co-Speaker: Doris Kao, PharmD, BCPS, FCSHP
                              Supervisor, Drug Information Services | Kaiser Permanente

Friday, October 27 | 8:30am - 9:30am

Tech Tips for Efficient Precepting: Streamlining the Process for New Practitioners

Course Description: This session will discuss a few "hacks" to decrease time on certain tasks when planning for rotations. This will include tips on using technology to your advantage (i.e. Google Forms, Sheets, etc.)
Learning Objectives:
  1. Describe applications that can be used towards organizational tasks when planning a rotation. 
  2. Identify strategies that will allow for optimal allocation of time and effort when having learners on rotations.
Track: Preceptor Development
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Emily Chan, PharmD, BCACP
                              Assistant Professor 
| Touro University California 
Co-Speaker: Melissa Kirkpatrick, PharmD, BCACP
                              Assistant Professor | Touro University California 

Friday, October 27 | 8:30am - 9:30am

Feeling Salty About Normal Saline: Rethinking Fluid Resuscitation

Course Description: The ideal fluid for resuscitation has yet to be identified. This course will review the types of fluids available and discuss literature regarding their use.
Learning Objectives:
  1. Explain a revised model of transcapillary fluid movement.
  2. Compare and contrast different types of intravenous fluids used for resuscitation.
  3. Discuss literature comparing large volume resuscitation with various crystalloid and colloid fluids.
Track: Therapy Management
Content Level: Level 2: Working Knowledge
Speaker: Paul Jisuen Wong, PharmD, BCCCP
                 Assistant Professor of Clinical Pharmacy 
| University of Southern California School of Pharmacy

Friday, October 27 | 8:30am - 9:30am

Shifting the Paradigm: Novel Targets in Heart Failure Therapy

Course Description: To offer a review of the evidence of Sacubitril/Valsartan and Ivabradine as well as reflect on their place in the management of chronic heart failure.
Pharmacist Objectives:
  1. Discuss new therapy options in the management of chronic heart failure.
  2. Review the evidence regarding the use of these agents in chronic management of heart failure.
  3. Highlight clinical pearls for incorporating these agents into practice based on most recent guideline recommendations.
Track: Cardiovascular
Content Level: Level 2: Working Knowledge
Speaker: Kristen E. Tasca, PharmD, BCPS
                     Clinical Pharmacist | Cedars-Sinai Medical Center

Friday, October 27 | 8:30am - 9:30am

Clinical Pearls for Pediatric Asthma Care

Course Description: Asthma is the most common pediatric chronic condition.  Proper use of medications as well as development of treatment plans will improve outcomes.  The pharmacist can play a key role in management.
Learning Objectives:
  1. Explain the current NHLBI guidelines and be prepared to implement the 2017/2018 revision.
  2. Describe the elements from the patient interview for new and follow-up consultation to assess patient needs and areas for improvement.
  3. Develop patient treatment plans for asthma, referrals and metrics for documentation.
  4. Describe how the NCQA and HEDIS metrics applies to healthcare systems and the devices used for treating and evaluating asthma in children and young adults.
Track: Therapy Management
Content Level: Level 2: Working Knowledge
Speaker: Scott Takahashi, PharmD, FCSHP, FASHP
                Pediatric Ambulatory Care Pharmacist
 | Kaiser Permanente

Friday, October 27 | 10:15am - 11:15am

Keynote Presentation

Course Description: TBA
Learning Objectives:
  1. TBA
Track: Keynote 
Speaker: Joe Kiani
                      Founder | Patient Safety Movement

Friday, October 27 | 11:30am - 12:30pm

Combating the Opioid Epidemic: Innovative Strategies in the Emergency Department

Course Description: In this seminar, we will briefly review common opioid usage and prescribing patterns in the emergency department and focus on strategies that you can implement in your ED to address the opioid epidemic. We will discuss alternatives to opioids, including lidocaine and ketamine, and implementing programs in the ED, such as dispensing naloxone from the ED and buprenorphine induction and medication-assisted treatment in the ED. 
Learning Objectives:
  1. Describe prescribing patterns and common indications for opioids in the emergency department (ED).
  2. List the current literature on alternatives to opioids in the ED. 
  3. Describe innovative strategies, such as medication-assisted treatment (MAT) induction therapy and dispensing naloxone from the ED.
Track: Therapy Management
Content Level: Level 2: Working Knowledge
Co-Speaker: Kevin Kaucher, PharmD
                              Clinical Pharmacy Specialist, Emergency Department 
| Denver Health Medical Center
Co-Speaker: Kimberly Won, PharmD
                              Assistant Professor | Chapman University School of Pharmacy 

Friday, October 27 | 1:00pm - 2:00pm

Beyond Graduation & More: Career Transitions

Course Description: Brief formal presentation and Q&A panel to present pearls for transitioning from student to resident, resident to new practitioner, and new practitioner to leadership roles in practice. 
Learning Objectives:
  1. Identify challenges often faced by students as they transition from student to resident.  Identify challenges often faced by residents and new practitioners.  Discuss strategies for successful transition from one setting to another.  Discuss opportunities for career development during residency and as a new practitioner.  
Track: Student Programming
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Christine Cadiz, PharmD, MA, BCPS
                              Assistant Professor of Clinical Sciences 
| Keck Graduate Institute School of Pharmacy
Co-Speaker: Thomas Lupton, PharmD
                              Informatics Specialist 
| Children's Hospital of Los Angeles 
Co-Speaker: Nicole Nguyen, PharmD, BCPS
                               Clinical Pharmacist 
| UCSF Medical Center
Co-Speaker: Pete Fowler, PharmD, MBA, BCPS
                               Ambulatory Care Pharmacist 
| Kaiser Permanente

Friday, October 27 | 1:30pm - 2:30pm

Antibiotic Stewardship Program:  Implementing the New Joint Commission & CDC ASP Standards

Course Description: This presentation will review the CDC Core Elements & Joint Commission standards, challenges faced trying to implement them, and strategies for success. 
Learning Objectives:
  1. List the CDC Core Elements for hospital Antibiotic Stewardship Programs. For each of the core elements, list documents or procedures required to meet the criteria.
  2. List ways to track antimicrobial usage and bacterial resistance.
  3. List how IT can help implement many of the CMS core elements.
  4. Explain the differences between rapid diagnostic platforms to standard culture methods of organism identification. 
  5. Design methods for optimal utilization of rapid diagnostic results into your institution’s stewardship program.
Track:  Infectious Disease
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Olga DeTorres, PharmD, FASHP, BCPS-ID
                               Antimicrobial Stewardship Clinical Pharmacist | O'Connor Hospital 

Co-Speaker: 
Emi Minejima, PharmD
                              Assistant Professor of Clinical Pharmacy
 | University of Southern California School of Pharmacy
                     

Friday, October 27 | 1:30pm - 2:30pm

Mamma Mia! Infections and Immunizations in Pregnant Patients: What's Appropriate, What's Not, and Everything In-Between

Course Description: Analyze what is safe and recommended antimicrobial therapy in pregnant patients with common infections and what is not. Review immunizations recommendations the patient needs and what to avoid.
Learning Objectives:
  1. List antimicrobial agents that are safe and effective in pregnancy.
  2. Provide recommendations for the immunization of pregnant patient.
  3. Be able to explain what agents should be avoided during pregnancy.
Track:  Infectious Disease
Content Level: Level 2: Working Knowledge
Speaker: Monica Donnelley, PharmD, BCPS-AQ ID, AAHIVP
                    Senior Pharmacist, Infectious Diseases
 | University of California Davis Health, Touro University College of Pharmacy

Friday, October 27 | 1:30pm - 2:30pm

What is a Pharmacist Doing on the Palliative Care Team? Tertiary and Community Hospital Experiences

Course Description: Palliative Medicine is a relatively new field of medicine and the role of the clinical pharmacist is being developed as programs continue to grow. This session will highlight the importance of pharmacist in palliative teams and also discuss interventions and outcomes achieved by pharmacists in this role. This session will also discuss strategies to gain expertise and experience in this specialty to support the integration of pharmacists into a palliative care team.
Pharmacist Objectives:
  1. Compare and contrast palliative and hospice care.
  2. Define the role of the pharmacist in a transdisciplinary palliative care team.  
  3. Develop strategies to integrate pharmacists into a palliative care team. 
Technician Objectives:
  1. Compare and contrast palliative care and hospice care.
  2. Describe the role of the pharmacist on an inpatient palliative care team.
  3. Compare and contrast the pharmacist role between tertiary and community hospital palliative care teams. 
Track: Practice Management
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Dharma Naidu, PharmD, BCOP
                               Clinical Pharmacy Specialist
 | Community Hospital of the Monterey Peninsula
Co-Speaker: Kasey Malotte, PharmD, BCPS
                              Clinical Pharmacist Supportive Care Medicine
 | Cedars Sinai Medical Center

Friday, October 27 | 1:30pm - 2:30pm

The Emerging Technician Practice

Course Description: This course will describe issues within the California legislator and Board of Pharmacy that may affect the pharmacy technician practice.  
Pharmacist Objectives:
  1. List the impact of Advanced Practice Pharmacist (APP) to the pharmacy technician practice.
  2. Describe the Pharmacy Practice Model Initiative (PPMI). 
  3. Describe current regulations impacting pharmacy technicians.
  4. Explain new regulations that affect the pharmacy technician role and practice.
Technician Objectives:
  1. List the impact of Advanced Practice Pharmacist (APP) to the pharmacy technician practice.
  2. Describe the Pharmacy Practice Model Initiative (PPMI). 
  3. Describe current regulations impacting pharmacy technicians.
  4. Explain new regulations that affect the pharmacy technician role and practice.
Track: Regulatory Issues/Legislation
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Rachael Ortiz, CPhT, MBA
                               Business Systems Analyst
 | Dignity Health
Co-Speaker: Thomas Harper, BS, CPhT
                              Clinical Pharmacy Technician 
| UC Davis Health System

Friday, October 27 | 1:30pm - 2:30pm

Multiple Sclerosis Part 1:  Understanding the Disease Multiple Sclerosis

Course Description: This presentation will provide an overview of multiple sclerosis (MS), our changing understanding of its pathophysiology and natural history, as well as, our evolving approaches to treatment. MS is disease that affects more than 400,000 persons in the United States. It is the leading cause of serious physical disability in young working-age individuals, disproportionately affecting women. Despite the fact that 10 high risk and costly MS medicines have been brought to the market over the past 10 years, the last national MS treatment guidelines were published in 2008. 
Learning Objectives:
  1. Describe Multiple Sclerosis (MS), its management and the goals and expectations of treatment.
  2. Compare and contrast all disease-modifying treatments (DMT) used to treat MS with respect to mechanism of action, side effects, efficacy, impact on disease progression, administration, and cost.
  3. Identify critical components of consultations for MS patients on DMTs.
Track: Specialty Drugs
Content Level: Level 2: Working Knowledge
Speaker: Shilpa Anil Klocke, PharmD, BCPS
                     Clinical Pharmacy Specialist-Neurology 
| Kaiser Permanente - Colorado
Friday, October 27 | 2:45pm - 3:45pm

Beyond the Scope of Glycemic Control- Impact of Newer Diabetes Medications

Course Description: Diabetes is associated with multiple chronic complications and metabolic disorders.  Pharmacists, as partners in health care teams, need to keep abreast of the most current medical evidence for treating diabetes and related complications such as cardiac and obesity. The purpose of this program is to discuss the latest diabetes treatment guidelines, review the literature and evaluate the impact diabetes medications have on cardiac, renal function and obesity outcomes.
Learning Objectives:
  1. Describe the newest American Diabetes Association treatment guidelines for helping patients achieve individualized glycemic goals.
  2. Evaluate outcomes evidence from key publications.
  3. Use evidence from studies discussed to evaluate the efficacy and additional outcomes of diabetes treatments which can be applied to clinical practice.
Track: Breaking News
Content Level: Level 2: Working Knowledge
Speaker: Candis Morello, PharmD, CDE
                     Professor of Clinical Pharmacy
| UCSD School of Pharmacy and VA San Diego
Friday, October 27 | 2:45pm - 3:45pm

Updates in Heart Failure Management

Course Description: This course will review the updates in heart failure management since the 2013 ACCF/AHA Guideline for the Management of Heart Failure.
Learning Objectives:
  1. Review the updates in pharmacologic therapies since the 2013 ACCF/AHA Guidelines in Management of Heart Failure.
  2. Describe the patient criteria for a patient to be placed on a angiotensin receptor-neprilysin inhibitor (ARNI) and/or sinoatrial node modulator.
  3. Assess the appropriateness of a heart failure patient's guideline-directed medical therapy.
  4. Identify the pharmacologic agent that is recommended in a specific subset of patients with heart failure with preserved ejection fraction to reduce rehospitalizations.
  5. Evaluate new literature for managing comorbid conditions, particularly hypertension and anemia.
Track: Cardiovascular
Content Level: Level 2: Working Knowledge
Speaker: Jocelyn Chaing, PharmD
                     Congestive Heart Failure Pharmacist
| Cedars-Sinai Medical Center
Friday, October 27 | 2:45pm - 3:45pm

Identifying and Giving Effective Feedback and Evaluations to High Performers

Course Description: An introduction to the concept of feedback; Review of key elements and techniques for effective feedback; Identifying and giving feedback to high performing students; Opportunity to share best practices with fellow attendees.
Learning Objectives:
  1. Describe the basic concepts of feedback.
  2. Identify high performing students.
  3. Assess and utilize key elements and techniques for effective feedback for high performers Sharing best practices.
Track: Preceptor Development
Content Level: Level 2: Working Knowledge
Speaker: Elaine Law, PharmD, BCPS, FCSHP
                     Assistant Clinical Professor
| University of the Pacific, Thomas J. Long School of Pharmacy
Friday, October 27 | 2:45pm - 3:45pm

Pharmacy Law Updates 2017

Course Description: Presentation of new federal and state pharmacy laws and regulations in 2017 with a look forward to what may be approved in the future.
Pharmacist & Technician Objectives:
  1. List the new California pharmacy laws and regulations for 2017.
  2. Describe how the new laws and regulations in California impact the practice of a pharmacist.
  3. List new federal laws and regulations that impact the practice of pharmacy in California.
  4. List the important pending laws and regulations in California for 2017.
Track: Regulatory Issues/Legislation
Content Level: Level 2: Working Knowledge
Speaker: Jim Pinder, JD, MBA
                     Associate Professor
| Loma Linda University School of Pharmacy
Friday, October 27 | 2:45pm - 3:45pm

Interventional Oncology and Drug-Eluting Beads: A Primer for New Practitioners

Course Description: This course will describe the rationale and process of trans-arterial chemo embolization which utilizes drug-eluting beads to delivery chemotherapy.
Learning Objectives:
  1. Review the pathophysiology and risk factors of HCC.
  2. Describe the TACE procedure and its use in HCC.
  3. Explain the rationale for using drug-eluting beads to deliver chemotherapy.
  4. Describe the preparation process of TACE orders.
  5. Explain the differences in each drug-eluting bead preparation with chemotherapy.
Track: Specialty Drugs
Content Level: Level 1: No Prior Knowledge
Speaker: Jaclyn Jaskowiak, Pharm.D., BCPS
                     Clinical Pharmacist
| UC San Diego Health
Friday, October 27 | 3:00pm - 4:00pm

Student Loan Repayment Strategies, Maximizing Employer Benefits, Creating Efficient Money Moves

Course Description: We continue to help pharmacists and other medical professionals reduce their student loan debts, continue to save in the most efficient areas for retirement, and maximize their benefits through work.
Learning Objectives:
  1. Create financial plans than cannot fail under any economic circumstances. Create flexibility and control while focusing on Protection, Savings, Growth and Debt Management.
Track:  Student Programming
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Jimmy Diehl, MBA, CFBS
                              Financial Advisor, MBA, CFBS, Managing Associate | Mass Mutual Financial Group
Co-Speaker: Wesley Yamada, RICP
                              Supervisor, Financial Designer | Furstner Group

Friday, October 27 | 4:00pm - 5:00pm

HCV Treatment Updates for Clinicians

Course Description: This session will explain how study results in HCV apply to clinical practice, discuss significant developments and strategies in HCV therapy, and describe drug ADEs and strategies for HCV management.
Learning Objectives:
  1. Discuss the recent data on current HCV treatments.
  2. Individualize HCV treatment regimens based on patient-specific disease conditions.
  3. Discuss the significant drug-drug interactions of direct-acting antivirals.
  4. List adherence strategies for HCV management.
Track:  Infectious Disease
Content Level: Level 2: Working Knowledge
Speaker: Jerika Lam, PharmD, AAHIVP, FCSHP
                     Assistant Professor
| Chapman University School of Pharmacy
Friday, October 27 | 4:00pm - 5:00pm

2017 Legislative Update

Course Description: This session will review the latest issues in pharmacy legislation from CSHP’s legislative advocacy firm, Weideman Group. Get the latest information from the experts in Sacramento regarding legislation which may impact pharmacy practice and healthcare.
Learning Objectives:
  1. List key pharmacy/healthcare legislation and regulations from 2017.
  2. Discuss CSHP-supported legislation.
Track:  Regulatory Issues/Legislation
Content Level: TBA
Speaker: Tim Valderrama
                     Managing Director
| Weideman Group
Friday, October 27 | 4:00pm - 5:00pm

Biosimilars from A to xyzz

Course Description: This presentation will provide pharmacists and technicians with basic information concerning biosimilars -- including what they are, how they are approved, and how they can be utilized.
Pharmacist Objectives:
  1. Explain the definition of a biosimilar, the legislative basis for approval of biosimilars, and the relationship of biosimilars to reference products.
  2. Describe the FDA review process and requirements for a biosimilar to be approved.
  3. Identify currently-approved biosimilars and future targets for biosimilars.
  4. Explain the potential of biosimilars for providing equivalent care with possible cost-savings.
Technician Objectives:
  1. Explain the definition of a biosimilar, the legislative basis for approval of biosimilars, and the relationship of biosimilars to reference products.
  2. Describe the FDA review process and requirements for a biosimilar to be approved.
  3. Identify currently-approved biosimilars and future targets for biosimilars.
  4. Explain the potential of biosimilars for providing equivalent care with possible cost-savings.
Track:  Specialty Drugs
Content Level: Level 1: No Prior Knowledge
Speaker: Jennifer M. Day, PharmD
                     Pharmacist Project Manager
| Kaiser Permanente Drug Information Services
Friday, October 27 | 4:00pm - 5:00pm

Impulse Control in Children and Adolescents: Diagnostic Challenges and Treatment Options

Course Description: Evidence to support pharmacologic treatment of impulse control in children and adolescents is rooted in the primary diagnosis. While impulsivity can present in numerous mental health disorders, Attention Deficit Hyperactivity Disorder (ADHD) specifically list impulsivity in its diagnostic criteria, and other mental health diagnoses such as bipolar disorder (BD), disruptive mood dysregulation disorder (DMDD) and autism spectrum disorder (ASD) contain key diagnostic features that are closely related to impulsivity. It is important for pharmacists to understand the differential diagnosis process for impulse control disorders in youth as the treatment for the impulse control can vary widely based on the primary diagnosis. This program will aim to educate the audience on those differential diagnoses and the recommended treatments for impulsivity in children based on their primary mental health disorder.
Learning Objectives:
  1. Differentiate between the varying presentations of impulsivity in youth with attention-deficit hyperactivity disorder (ADHD), bipolar disorder (BD), disruptive mood dysregulation disorder (DMDD) and autism spectrum disorder (ASD).
  2. Describe evidence-based treatment options for impulsivity based on the primary mental health diagnosis.
  3. Given a specific patient case, recommend appropriate treatment for the presenting impulse control disorder.
Track:  Therapy Management
Content Level: Level 2: Working Knowledge
Speaker: Julie Dopheide, PharmD, BCPP, FASHP
                     Professor of Clinical Pharmacy, Psychiatry, and the Behavioral Sciences
| USC School of Pharmacy
Friday, October 27 | 4:00pm - 5:15pm

Conducting and Publishing Clinical Research: A Primer for Residents and New Practitioners

Course Description: 1) Strategies for conducting successful residency research projects will be discussed. 2) The publication process and best practices for integrating clinical practice/scholarship will be reviewed.
Learning Objectives:
  1. Compare and contrast feasible and successful research projects.
  2. Describe the research process from idea generation to manuscript development.
Track:  Preceptor Development
Content Level: Level 1: No Prior Knowledge
Speaker: Sachin Shah, PharmD
                     Associate Professor of Pharmacy Practice/RPD
| University of the Pacific
Friday, October 27 | 4:00pm - 6:00pm

Overview and update on the California state Board of Pharmacy Compounding Regulations

Course Description: The session will provide an overview of the California State Board of Pharmacy’s compounding regulations which went into effect on 1/1/17.  This session will help demystify the new compounding regulations for California Code of Regulations section 1735 et seq. for general compounding and California Code of Regulations section 1751 et seq. for sterile compounding.  Additionally; updated information on any pending changes will discussed where applicable. Following the presentation there will be a lengthy question and answer period to permit attendees with questions to leave with clearer understanding of the compounding regulations.
Pharmacist Objectives:
  1. Describe compounding regulations in the California Code of Regulations section 1735 et seq. for general compounding and California Code of Regulations section 1751 et seq. for sterile compounding.
  2. Describe any possible updates on the compounding law.
  3. Describe what compounding is and is not.
Technician Objectives:
  1. Describe compounding regulations in the California Code of Regulations section 1735 et seq. for general compounding and California Code of Regulations section 1751 et seq. for sterile compounding.
Track:  Regulatory Issues/Legislation
Content Level: Level 2: Working Knowledge
Speaker: Christine Acosta, PharmD
                     Supervising Inspector
| California State Board of Pharmacy
Friday, October 27 | 4:15pm - 5:15pm

Preparing for the NAPLEX and CPJE Exams

Course Description: TBA
Learning Objectives:
  1. TBA
Track:  Student Programming
Content Level: Level 1: No Prior Knowledge
Speaker: Karen Shapiro, PharmD, BCPS
                     Director
| RX Prep, Inc.

- Seminar 2017 Sessions - Saturday, October 28, 2017 -


Saturday, October 28 | 8:00am - 9:00am

Writing a Pharmacy Disaster Plan Compliant with Centers for Medicare & Medicaid Services (CMS) Emergency Preparedness Rule

Course Description: Often pharmacy emergency preparedness and disaster plans are either incomplete or are not well coordinated with the institutional plan.  Here are some ways to add details to the plan in compliance with new regulations.  To insure that the written plan can be put into action, we will describe staff education and training exercises.
Learning Objectives:
  1. Explain how to establish and coordinate the pharmacy response to natural and human-caused disasters.
  2. List the emergency preparedness requirements for the pharmacy department.
  3. Develop the criteria for a pharmacy disaster plan that integrates emergency planning for your facility.
  4. Suggest training exercises to insure staff competency with the plan.
Track: Regulatory Issues/Legislation
Content Level: Level 1: No Prior Knowledge
Speaker: Sandra Leigh Bardas, RPh FCSHP
                     Consultant Pharmacist | Pharmaceutical Cares

Saturday, October 28 | 8:00am - 9:00am

Multiple Sclerosis Sclerosis Part 2: Understanding the Treatment Options

Course Description: With more than a dozen disease modifying treatments (DMT) for multiple sclerosis (MS) available in the US, treatment strategies and outcomes evaluations are still evolving. This presentation will review MS treatment paradigms. MS is disease that affects more than 400,000 persons in the United States. It is the leading cause of serious physical disability in young working-age individuals, disproportionately affecting women. Despite the fact that 10 high risk and costly MS medicines have been brought to the market over the past 10 years, the last national MS treatment guidelines were published in 2008.
Learning Objectives:
  1. Describe the goals and expectations of treatment for MS.
  2. Review changing treatment strategies and outcome evaluation.
  3. Compare and contrast all disease-modifying treatments (DMT) used to treat MS with respect to mechanism of action, side effects, efficacy, impact on disease progression, administration, and cost.
  4. Identify critical components of consultations for MS patients on DMTs.
Track: Specialty Drugs
Content Level: Level 1: No Prior Knowledge
Speaker: Shilpa Anil Klocke, PharmD, BCPS
                     Clinical Pharmacy Specialist-Neurology | Kaiser Permanente-Colorado

Saturday, October 28 | 8:00am - 9:00am

Updates in HIV prevention, a Focus on PrEP and PEP 

Course Description: Recent papers that have been published in the field of cardiology will be discussed.
Learning Objectives:
  1. Discuss current strategies to prevent HIV transmission.
  2. Identify therapeutic agents used in pre and post exposure prophylaxis of HIV infection.
  3. Describe the adverse effects and drug interactions associated with pre and post exposure prophylaxis.
Track:  Infectious Disease
Content Level: Level 2: Working Knowledge
Speaker: Betty J. Dong, PharmD, FASHP, FAPHA, FCCP, AAHIVP
                     Professor of Clinical Pharmacy and Family and Community Medicine | University of California Schools of Pharmacy and Medicine

Saturday, October 28 | 9:15am - 10:45am

Resiliency Medicine: Immunizing for Stress

Course Description: The evidence abounds. A compelling body of research estimates that psychosocial stressors can play a contributing role in aggravating and even initiating pathology. Patient stress can limit the efficacy of our efforts to achieve optimal care management AND our own practitioner stress can lead to errors in judgment, dissatisfaction and burnout. This topic belongs squarely within the pharmacist's scope of practice and urgently calls for an expanded approach to caring for our patients AND caring for ourselves. This is an experiential workshop. We will explore tools, techniques and resources to help build resiliency for ourselves and for our patients. For more see Pharmacy Today article click here.
Pharmacist Objectives:
  1. Demonstrate and immediately apply easy-to-use stress reducing techniques, insights and perspectives to improve their own wellbeing.
  2. Identify the rapidly emerging resiliency resources and references in the professional and consumer literature.
  3. Complete a learning assessment and resource checklist.
Technician Objectives:
  1. Demonstrate and immediately apply easy-to-use stress reducing techniques, insights and perspectives to improve their own wellbeing.
  2. Identify the rapidly emerging resiliency resources and references in the professional and consumer literature.
  3. Complete a learning assessment and resource checklist.
Track: Practice Management
Content Level: Level 1: No Prior Knowledge
Speaker: Eleanor M. Vogt, B.S. Pharmacy, M. Ed., PhD
                     Health Sciences Clinical Professor | University of California San Francisco School of Pharmacy

Saturday, October 28 | 9:15am - 10:15am

New Medications in ESRD

Course Description: Review of new agents to manage sequelae of end-stage renal disease; review of use of novel oral anticoagulants (NOACs) in patients with significant renal dysfunction.
Learning Objectives:
  1. Evaluate new treatments for hyperphosphatemia, hyperkalemia, and secondary hyperparathyroidism.
  2. Review key differences in novel oral anticoagulants for use in renal dysfunction.
  3. Discuss clinical considerations for use of new agents, comparing with current standards of therapy.
Track: Breaking News
Content Level: Level 2: Working Knowledge
Speaker: Melissa Kirkpatrick, PharmD, BCACP
                     Assistant Professor | Touro University California

Saturday, October 28 | 9:15am - 10:15am

A Triple Threat: Combining Direct Oral Anticoagulants with Dual Antiplatelet Therapy

Course Description: This seminar will describe indications for combining direct oral anticoagulants (DOAC's) with dual antiplatelet drug therapy (DAPT) and review the recent literature describing its safety and efficacy.
Learning Objectives:
  1. Explain the pathophysiological basis for combining anticoagulation with dual antiplatelet therapy in atrial fibrillation and acute coronary syndrome.
  2. Appraise the recent literature evaluating the safety and efficacy of combining direct oral anticoagulants with dual antiplatelet therapy.
  3. Develop evidence-based treatment recommendations for patients with indications for anticoagulation and antiplatelet therapy.
Track: Cardiovascular
Content Level: Level 1: No Prior Knowledge
Speaker: Felix K. Yam, Pharm.D., M.A.S., BCPS-AQ Cardiology
                     Associate Clinical Professor | UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences

Saturday, October 28 | 9:15am - 10:15am

Now what? - Meeting Pain Management Needs in Patients with Opioid Use Disorder

Course Description: This presentation aims to open the door for a discussion about general principles of treating REAL pain that patients experience while maintaining addressing opioid use concerns and safety.
Pharmacist Objectives:
  1. Define opioid use disorder.
  2. Identify techniques to maintain a therapeutic relationship.
  3. Describe pharmacotherapeutic options for pain management in those with opioid use disorder.
Technician Objectives:
  1. Define opioid use disorder.
  2. Identify techniques to maintain a therapeutic relationship.
Track: Therapy Management
Content Level: Level 2: Working Knowledge
Speaker: Kasey Malotte, PharmD, BCPS
                      Palliative Care Clinical Pharmacist | Cedars Sinai Medical Center

Saturday, October 28 | 10:00am - 11:00am

Mindful Interviewing: How to Make a Meaningful Connection

Course Description: Interviewing is fraught with tension and anxiety - it's not a natural process. In order to transform the experience into one that is instead empowering, we will explore the truth behind interviewing, namely that it's more than trying to win a job. Instead, it is about the mindful practice of "connecting authentically and exploring what's possible" so you ultimately match with the job of your dreams.
Learning Objectives:
  1. Transform interviewing into an experience of connection and personal empowerment that will help you match with the position of your dreams.
Track: Student Programming
Content Level: Level 1: No Prior Knowledge
Speaker: Lori Wallace
                      President, Chief Recruiter | igMedical

Saturday, October 28 | 10:30am - 11:30am

Implementation of an Automated IV Workflow and Dose Tracking System

Course Description: This course will provide education on the impacts of implementing an automated IV workflow and dose tracking system at acute care hospitals within Palomar Health utilizing a collaborative workgroup.
Pharmacist Objectives:
  1. Describe the pharmacist's role utilizing an automated IV workflow system.
  2. Identify how an automated IV workflow solution can impact patient safety, regulatory compliance, labor efficiency, product waste, timely recalls and customer service.
  3. Outline steps necessary to implement a dose tracking system.
Technician Objectives:
  1. Describe an example of how a product is compounded using an automated IV workflow system
  2. Explain how a dose tracking system and automated IV workflow solution can impact a technician's daily routine.
  3. Identify common issues that pharmacy technicians are involved in troubleshooting during implementation of automated workflow solutions.
Track: Practice Management
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Le Du, PharmD
                              Pharmacist | Palomar Medical Center
Co-Speaker: Kelly McPhee
                              Automation Specialist Pharmacy Technician | Palomar Medical Center

Saturday, October 28 | 12:30pm - 2:30pm

Clinical Trial Design and Bio-statistics: What do I really need to know?

Course Description: Stats are often taught in a manner that obfuscates the critical skills required for practice. This session clearly outlines key concepts required to adequately evaluate literature in daily practice.
Learning Objectives:
  1. Determine statistical and clinical significance for a given outcome in a study
  2. Discuss the determinants of power and evaluate when power is relevant
  3. Calculate a number needed to treat and a number needed to harm.
  4. Describe the advantages and disadvantages of the use of surrogate markers, composite endpoints, and subgroups in medical literature.
  5. Discuss strengths and weaknesses of the evolving methods of current drug study designs
Track: Student Programming
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Evan Williams, PharmD, MBA, BCPS, BCACP
                              Assistant Professor of Pharmacy Practice | Roseman University of Health Sciences
Co-Speaker: Vasudha Gupta, PharmD, BCACP, CDE
                              Assistant Professor of Pharmacy Practice | Roseman University of Health Sciences

Saturday, October 28 | 12:45pm - 2:00pm

Panel Discussion: Navigating Your Career

Course Description: Navigating the myriad of options in our profession can be daunting, especially early on in one’s career.  To support students and new practitioners, we are kicking off a new session especially designed for you which will include topics such as:
  • What career path should I choose
  • Why I should consider leadership
  • How do I navigate work-life in my career
  • Professional involvement-key to growth and career satisfaction
  • How do I find mentors

We are bringing together leaders from across the profession to facilitate these sessions and provide you with networking opportunities.  We hope you will join us and look forward to your feedback on how we can continue to support your professional growth.

Learning Objectives:

  1. TBA

Track: TBA
Room: Concorde B
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Rita Shane, PharmD, FASHP, FCSHP
                              Chief Pharmacy Officer | Cedars-Sinai Medical Center
Co-Speaker: Loriann DeMartini, PharmD
                              Chief Executive Officer | California Society of Health-System Pharmacists


Saturday, October 28 | 1:00pm - 2:00pm

Clinical Pharmacy Career Roundtable 

Course Description: Students and post-graduate trainees, join this dynamic networking session to gain insights on career pathways and opportunities within the clinical pharmacy profession. Interact directly with clinical pharmacists in different specialty practice areas via a speed-dating format to learn more about their training, experience, research and specialty. There will be 6 x 10 minute sessions where you will rotate to different tables depending on specialties that interest you! Attend to learn more about career opportunities in Pharmacy!
Track: Student Programming
Content Level: Level 1: No Prior Knowledge
Facilitator: Kim Nguyen, Doctor of Pharmacy, Candidate 2018
                      Student | Keck Graduate Institute, School of Pharmacy

Saturday, October 28 | 1:30pm - 2:30pm

Trending Now #New Drugs - Part 2

Course Description: Information pertinent to new drug approvals from the last year will be discussed for incorporation into current practice.
Pharmacist Objectives:
  1. Describe selected new drug approvals and trends at the Food and Drug Administration (FDA) from July 2016 through July 2017.
  2. Name and identify the mechanism of action and dosing considerations for valbenazine.
  3. Identify the novel targeted treatment option as part of combination therapy for acute myeloid leukemia.
Technician Objectives:
  1. List four or more new drug approvals by the FDA from July 2016 to July 2017.
  2. Name at least three new drugs approved for cancer indications.
  3. Identify the only two drugs approved, or likely to be approved, for the treatment of tardive dyskinesia.
Track: Breaking News
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Doris Kao, PharmD, BCPS, FCSHP
                              Supervisor, Drug Information Services | Kaiser Permanente
Co-Speaker: Timothy Chiu, PharmD, BCPS
                              Pharmacist Evidence Analyst & Strategist | Kaiser Permanente

Saturday, October 28 | 1:30pm - 2:30pm

 

Design and Conduct of the Residency Program - Addressing common areas of partial compliance

Course Description: This presentation will address the common partial compliance findings relating to ASHP Pharmacy Residency Programs Accreditation Standard 3 relating to the design and conduct of the residency program.
Learning Objectives:
  1. Determine if a learning experience description would meet the ASHP Accreditation Standard.
  2. Determine if a preceptor evaluation of a resident after completing a learning experience would meet the ASHP Accreditation Standard
  3. Develop activities for learning experience goals and objectives which would meet the ASHP Accreditation Standards.
  4. Create criteria based feedback for learning experience goals and objectives which would meet the ASHP Accreditation Standards.
Track: Preceptor Development
Content Level: Level 2: Working Knowledge
Speaker: Robert M. Mowers, PharmD, BCPS
                     Coordinator, Managed Care Pharmacy Services | UC Davis Medical Center

Saturday, October 28 | 1:30pm - 2:30pm

 

Ready, set, inject: Updates to Injectable Medications for Type 2 Diabetes

Course Description: This session will utilize case-based activities to review select injectable medications for treating T2DM. Active audience participation will be encouraged with the use of Poll Everywhere.
Pharmacist Objectives:
  1. Describe the newly approved insulin and insulin/GLP-1 combination products for treatment of type 2 diabetes mellitus.
  2. Explain the dosing and side effects of new insulin and insulin/GLP-1 combination products.
  3. Develop a patient-specific plan for switching from a long-acting insulin to insulin/GLP-1 combination product.
Technician Objectives:
  1. List the new insulin and insulin/GLP-1 combination products.
  2. Recall the new insulin products that may have lower risk for hypoglycemia.
  3. Identify patients who would benefit from additional counseling and support in regards to their insulin therapy.
Track: Therapy Management
Content Level: Level 2: Working Knowledge
Co-Speaker: Michael Kelly, PharmD, BCACP
                              Assistant Professor | Chapman University School of Pharmacy
Co-Speaker: Jelena Lewis, PharmD
                              Assistant Professor of Pharmacy Practice | Chapman University School of Pharmacy

Saturday, October 28 | 1:30pm - 2:30pm

 

A Collaborative Approach: Geriatric Patients & Post-ICU Care

Course Description: The geriatric patient population is particularly vulnerable to post-ICU syndrome and warrants integrated care from an interprofessional team to optimize post-ICU recovery and treatment.
Pharmacist Objectives:
  1. Define Post-ICU Syndrome and its risk factors.
  2. Describe collaborative approaches for critical care and geriatric pharmacist for post-ICU care.
  3. Apply knowledge of post-ICU care to a geriatric patient case.
Track: Therapy Management
Content Level: Level 2: Working Knowledge
Co-Speaker: Jessica Louie, PharmD, BCCCP
                              Assistant Professor | West Coast University School of Pharmacy
Co-Speaker: Aida Oganesyan, PharmD, BCGP
                              Assistant Professor of Pharmacy Practice | West Coast University School of Pharmacy

 Saturday, October 28 | 2:45pm - 3:45pm

 

Maximizing the Potential of your Automation through Application of Lean Principles

Course Description: This lecture aims to discuss how automation and lean tools can complement each other and transform pharmacy practice. Key performance indicators on cost, efficiency and safety will be shared.
Pharmacist Objectives:
  1. Describe the synergy between automation and lean six sigma.
  2. Discuss the transformational process of pharmacy practice through the use of automation and lean six sigma tools.
  3. Review key performance indicators on cost, efficiency and safety before and after the transformation
Technician Objectives:
  1. Describe the synergy between automation and lean six sigma.
  2. Discuss the transformational process of pharmacy practice through the use of automation and lean six sigma tools.
  3. Review key performance indicators on cost, efficiency and safety before and after the transformation
Track: Practice Management
Content Level: Level 2: Working Knowledge
Speaker: Rita K. Jew, PharmD, MBA, FASHP
                     Director of Pharmacy, Mission Bay Campus | UCSF Health

Saturday, October 28 | 2:45pm - 3:45pm

 

Legislative Update for 2018

Course Description: TBA
Learning Objectives:
  1. Identify components of new laws pharmacies must implement in 2018.
  2. Describe four recent regulation changes that will impact pharmacy practice in 2018.
  3. Identify future directions for regulation of pharmacy practice by the California Board of Pharmacy.
Track: Regulatory Issues/Legislation
Content Level: Level 2: Working Knowledge
Speaker: Ginny Herold, MS
                      Executive Officer | California State Board of Pharmacy

Saturday, October 28 | 2:45pm - 3:45pm

 

Pain Management by Pharmacists - A Practical Guide

Course Description: This program will provide the audience with practical tools that pharmacists can use to implement a basic pain management program that will provide safe pain relief and enhance patient experience.
Learning Objectives:
  1. List the primary areas involved in the assessment of patients in pain.
  2. Differentiate between acute and chronic pain, and discuss the individual features of each. Given a case scenario, provide an assessment of the patient and develop the initial treatment plan.
  3. Discuss the monitoring requirements for the patient receiving analgesic therapy, focusing on safety.
Track: Therapy Management
Content Level: Level 1: No Prior Knowledge
Speaker: Andrew Lowe, PharmD
                      Regional Vice-President - Clinical Services | Arrowhead Regional Medical Center/ Comprehensive Pharmacy Services

Saturday, October 28 | 4:00pm - 5:00pm

 

Electronic Surveillance Can Be a Good Thing! Development of a DOAC Medication Monitoring Program to Improve Patient Outcomes

Course Description: Learn about elements of an electronic surveillance program to ensure safe use of direct oral anticoagulants. Review the experience within Kaiser Permanente and how the development of medication safety tools have reduced medication misadventures, improved patient care experiences, and improved physician satisfaction. 
Learning Objectives:
  1. Identify common issues related to the use of DOAC.
  2. Describe electronic tools that can be used to identify clinical interventions to avoid DOAC related medication misadventures.
  3. Construct a medication monitoring program to ensure safe and appropriate use of DOAC medications.
Track: Cardiovascular
Content Level: Level 1: No Prior Knowledge
Speaker: Logan Saito, PharmD, BCPS
                      SCAL - Clinical Pharmacy Services Manager | Kaiser Permanente

Saturday, October 28 | 4:00pm - 5:00pm

 

Collaborating with Medical Residency Programs: Tools for Interprofessional Education Success

Course Description: :  It takes intentional collaborative effort to produce meaningful interpersonal educational experiences.  This presentation’s goal is to increase awareness of the wealth of recourses a hospital with a medical/family practice training program can provide an pharmacy residency training program.   Pharmacy residencies can benefit from this collaboration by 1) clinical rounding and understanding the care of the whole patient 2) clinical and bench research 3) diagnostic methodology ( radiology/pathology/microbiology…) 4) medical grand rounds, noon conference, morning report learning opportunities 5) clinical presentation skills via rounds and lectures 6) inter-professional decision making skills and 7) build a culture of collaboration
Learning Objectives:
  1. Discuss methodology you would use to colloborate with pharmacy student and resident training with medical/family practice residency program.
  2. Determine opportunities for inter-professional education.
  3. Explain tools you would use to increase credibility and engagement in graduate medical education departments.
Track: Preceptor Development
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Harminder Sikand, PharmD, FCSHP, FASHP, FCCP
                              Director of Clinical Services and Residency Program | Scripps Mercy Hospital
Co-Speaker: Winnie Thi, Pharm D, BCPS
                              Transition of Care Clinical Pharmacist | Scripps Mercy Hospital

Saturday, October 28 | 4:00pm - 5:00pm

 

Pharmacogenomics and Cancer Care - Defining the Role of Oncology Pharmacists in Precision Medicine

Course Description: This lecture will outline the evolving role of pharmacogenomics in oncology treatment and how oncology pharmacists can help implement precision medicine strategies in their practices.
Learning Objectives:
  1. Describe the role of pharmacogenomics for tailoring oncology care.
  2. Examine the current precision medicine practice models and the role of the oncology pharmacist.
  3. Discuss the main challenges of utilizing pharmacogenetic testing in clinical oncology practice.
Track: Specialty Drugs
Content Level: Level 1: No Prior Knowledge
Speaker: Mimi Lo, PharmD, BCPS, BCOP
                     Hematology/Oncology Clinical Pharmacist | UCSF Medical Center

 

- Seminar 2017 Sessions - Sunday, October 29, 2017 -


Sunday, October 29 | 8:00am - 9:00am

High Stakes of Social Determinants of Health & the Role Pharmacy Can Play 

Course Description: Estimates of up to 60% of health outcomes are determined by social determinants, such as food, transportation, etc. Optimal medication management is best achieved when social needs are also addressed.
Pharmacist Objectives:
  1. Describe social determinants of health and impact on health outcomes.
  2. Describe evidence based practices and models of care to address social non-medical needs.
  3. Describe the role of health system pharmacy in improving health outcomes through social and medical care integration.
  4. Discuss any new regulatory, legislative and payment models in addressing social needs.
Technician Objectives:
  1. Describe social determinants of health and impact on health outcomes.
  2. Describe evidence based practices and models of care to address social non-medical needs.
  3. Describe the role of health system pharmacy in improving health outcomes through social and medical care integration.
  4. Discuss any new regulatory, legislative and payment models in addressing social needs.
Track: Breaking News
Content Level: Level 2: Working Knowledge
Speaker: Annet Arakelian, PharmD, FCSHP, CPHQ
                     Executive Director, Medicare Strategy | Kaiser Permanente

Sunday, October 29 | 8:00am - 9:00am

Applying Learning Styles for More Effective and Efficient Teaching and Learning

Course Description: This course will review theories of teaching and learning that can serve as a helpful tool to provide effective and efficient learning experiences, including in the experiential setting.
Pharmacist Objectives:
  1. Determine your own teaching and learning style.
  2. Evaluate major learning styles.
  3. Identify tools to help assess student pharmacists and resident learning styles.
  4. Apply learning styles to develop educational activities and provide feedback, including in the experiential setting.
Technician Objectives:
  1. Determine your own teaching and learning style.
  2. Evaluate major learning styles.
  3. Identify tools to help assess student pharmacists and resident learning styles.
  4. Apply learning styles to develop educational activities and provide feedback, including in the experiential setting.
Track: Preceptor Development
Content Level: Level 1: No Prior Knowledge
Speaker: Anisa M. Abu-Ramaileh, PharmD, BCPS
                     Clinical Pharmacist Specialist | Cedars-Sinai Medical Center

Sunday, October 29 | 8:00am - 9:00am

Forge Your Path to Become a Competitive Pharmacy Residency Applicant

Course Description: Taking the best steps possible to become a competitive pharmacy residency applicant is more important than ever because the number of pharmacy students seeking residency training continues to increase. Starting the process early in pharmacy school offers the most options to choose from and helps sharpen the focus on which area of pharmacy to begin your career. Maximizing extracurricular activities, optimizing your Advanced Pharmacy Practice Experiences schedule, creating an effective curriculum vitae, and writing a persuasive letter of intent can significantly improve your chance of getting an interview with your desired programs.
Learning Objectives:
  1. Choose organizations and activities that will maximize your leadership, community service, and research experience.
  2. Write a persuasive letter of intent.
  3. Incorporate significant accomplishments in your curriculum vitae.
  4. Assist your preceptors to write strong letters of recommendation.
Track: Student Programming
Content Level: Level 1: No Prior Knowledge
Speaker: Rodney J. Gedey, PharmD, BCPS
                     Director, Drug Information Services | Envolve Pharmacy Solutions

Sunday, October 29 | 8:00am - 9:30am

The Pot Thickens: Updates in Medical Marijuana

Course Description: Per the Department of Health and Human Services, marijuana is the most used illicit drug in the US. pharmacists and technicians need to be informed about the benefits and risks of medical marijuana to ensure patient safety. Recent legal and therapeutic updates of medical marijuana will be presented including different products, pharmacology and effectiveness in treatment-resistant epilepsy and pain disorders.
Pharmacist Objectives:
  1. Summarize the recent legislative changes for medical marijuana in California.
  2. Differentiate the pharmacology, pharmacokinetic and pharmacodynamic properties of delta-9-tetrahydrocannabinol and cannabidiol.
  3. Discuss the published evidence for therapeutic effectiveness of medical marijuana for treatment-resistant epilepsy.
  4. Discuss the advantages and disadvantages of using medical marijuana for pain disorders.
Technician Objectives:
  1. Summarize the recent legislative changes for medical marijuana in California versus Federal Law.
  2. List available FDA-approved products related to cannabinoids
  3. Discuss the therapeutic effectiveness of medical marijuana for treatment-resistant epilepsy.
  4. Discuss the advantages and disadvantages of using medical marijuana for pain disorders.
Track: Breaking News
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Kelly C. Lee, PharmD, MAS, FCCP, BCPP
                              Associate Dean for Assessment and Accreditation | University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
Co-Speaker: Kimberly Tallian, PharmD, APH, BCPP, FASHP, FCCP, FCSHP
                              Advanced Practice Pharmacist - Psychiatry | Scripps Mercy Hospital, San Diego
Co-Speaker: Patricia A. Pepa, PharmD, MS
                              PGY2 Psychiatric Pharmacy Resident | University of California San Diego Health

Sunday, October 29 | 9:15am - 10:15am

Follow The Clot (A Case Based Review of Inpatient and Outpatient DVT/PE Treatment)

Course Description: This course will utilize patient cases to guide the audience through evidence-based management of a DVT/PE from development to resolution in the inpatient and outpatient settings.
Learning Objectives:
  1. Describe subjective and objective findings in a patient with DVT/PE.
  2. Using the 2016 CHEST guidelines updates, compare and contrast direct oral anticoagulants with focus on patient specific factors.
  3. Develop a patient care plan including monitoring parameters, side effects, drug-drug interactions, and patient education.
  4. Describe appropriate use of reversal agents for direct oral anticoagulants.
Track: Cardiovascular
Content Level: Level 2: Working Knowledge
Co-Speaker: Laura Tsu, PharmD, BCPS, BCGP
                              Assistant Professor of Pharmacy Practice | Chapman University School of Pharmacy
Co-Speaker: Tania Gregorian, PharmD
                              Assistant Professor of Pharmacy Practice | Chapman University School of Pharmacy

Sunday, October 29 | 9:15am - 10:45am

ABCD's of COPD, including New Updates from the WHO GOLD 2017 Guidelines

Course Description: Provide an update to the GOLD COPD 2017 Guidelines, including new revisions in patient assessment and treatment algorithm for stable COPD. Review medications and treatment of COPD exacerbations.
Learning Objectives:
  1. Discuss the new updates for the 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines.
  2. Determine a patient's classification of COPD according to the 2017 GOLD guidelines.
  3. Select the appropriate treatment for stable COPD based on the new treatment algorithm.
  4. Identify the clinical presentation and treatment strategy for a COPD patient with an acute exacerbation.
  5. Evaluate the evidence based recommendations for the treatment of stable COPD and COPD exacerbations.
Track: Breaking News
Content Level: Level 2: Working Knowledge
Co-Speaker: Trang (Susan) Nguyen, PharmD, BCACP
                              Assistant Professor of Pharmacy Practice | Roseman University of Health Sciences
Co-Speaker: H. Stephen Lee, PharmD, MSc, BSc
                              Assistant Professor of Pharmacy Practice | Roseman University of Health Sciences

Sunday, October 29 | 9:15am - 10:45am

Beyond the PharmD Degree: An overview of Post Graduate Programs

Course Description: This session will be provide information on different types of post graduate training such as PGY1/PGY2 pharmacy residencies, community practice residencies, managed care residencies, fellowships, masters programs and PhD programs.    A description of each program type will be reviewed along with information on: where to gather information about available positions,  the skills that the applicant is likely to gain and how this translates into future career opportunities.  Half of the session will be a panel-based interactive format where audience members can ask panelists about the timeline for application, where and what information to gather/consider before applying, how to strengthen their curriculum vitae, and career path.
Track: Student Programming
Content Level: Level 1: No Prior Knowledge
Co-Speaker: Maria Lopez, PharmD, AAHIVP
                              Residency Program Director, President | Mission Wellness Pharmacy
Co-Speaker: Cathi Dennehy, PharmD
                              Professor of Clinical Pharmacy, UCSF School of Pharmacy | UCSF
Co-Speaker: Leslie Floren, PharmD, MA, DABCP
                              Co-Director of the NIH-funded | UCSF Clinical Pharmacology Fellowship Training Program
Co-Speaker: Matthew Bryant, PharmD
                              Associate Director | Medical Affairs at Theravance Biopharma

Sunday, October 29 | 9:45am - 10:45am

Updates in the Management of Sepsis and Septic Shock: Are we still Surviving?

Course Description: In March, the International Surviving Sepsis Campaign released their new guidelines for the management of sepsis/septic shock; this CE will assimilate and present the recommendations for everyday use.
Learning Objectives:
  1. Compare and contrast the 2012 Surviving Sepsis Guidelines with the 2016 updates.
  2. Evaluate the literature behind the changes in the 2016 Surviving Sepsis Guidelines.
  3. Integrate the new guidelines into everyday practice.
  4. Analyze the evidence for the advantages/disadvantages to using balanced vs. un-balanced crystalloids.
  5. Justify the treatment and management in a given patient case.
Track: Infectious Disease
Content Level: Level 3: Advanced Knowledge
Speaker: Justin Kinney, PharmD, MA
                     Assistant Professor | Loma Linda University School of Pharmacy

Sunday, October 29 | 11:00am - 12:00pm

Medication A.R.E.A.S. Bundle: A Prescription Strategy for Value-Based Healthcare

Course Description: This course will provide participants with an overview of the US system, the importance of the MACRA in transforming healthcare, and a prescription strategy to support organization's quest for value.
Pharmacist Objectives:
  1. State the MACRAs Quality Payment Program and its role in the transition from volume to value.
  2. Describe the key measures that will be used to assess the transformation healthcare activities.
  3. Explain a prescription strategy that can be implemented across the continuum of care to optimize patient health outcomes, reduce total costs of care, and improve organization performance.
  4. Name the business capabilities and infrastructures necessary to successfully implement, support, and sustain the prescription strategy.
  5. Describe key strategies to build the most effective teams and expand one's geographic reach.
Technician Objectives:
  1. State the MACRAs Quality Payment Program and its role in the transition from volume to value.
  2. Describe the key measures that will be used to assess the transformation healthcare activities.
  3. Explain a prescription strategy that can be implemented across the continuum of care to optimize patient health outcomes, reduce total costs of care, and improve organization performance.
  4. Name the business capabilities and infrastructures necessary to successfully implement, support, and sustain the prescription strategy.
  5. Describe key strategies to build the most effective teams and expand one's geographic reach.
Track: Practice Management
Content Level: Level 2: Working Knowledge
Speaker: Elizabeth Oyekan, PharmD, FCSHP, CPHQ
                     Managing Principal | TGC PENROSE

Sunday, October 29 | 11:00am - 12:00pm

Development of ICU-specific Antibiograms to Guide Empiric Therapy of Hospital-acquired and Ventilator-associated Pneumonia

Course Description: A brief review of treatment recommendations from the 2016 IDSA/ATS Clinical Practice Guidelines for the management of HAP and VAP alongside a discussion of antibiograms through one institution's experience.
Learning Objectives:
  1. Describe the clinical utility of antibiograms for the management of infections.
  2. List benefits and limitations of presenting susceptibility data using patient, episode, or phenotype-based methods.
  3. Describe how to implement an ICU-specific antibiogram in order to direct empiric treatment of ICU-related Hospital-acquired or ventilator-associated pneumonia.
  4. Select an appropriate empiric treatment regimen for a patient with hospital-acquired (HAP) or ventilator-associated pneumonia (VAP) according to local susceptibility data and the 2016 IDSA/ATS Clinical Practice Guidelines for the management of HAP and VAP.
Track: Infectious Disease
Content Level: Level 2: Working Knowledge
Speaker: Katherine Gruenberg, PharmD, BCPS
                     Assistant Professor of Clinical Pharmacy | University of California San Francisco School of Pharmacy

Sunday, October 29 | 11:00am - 12:00pm

Role of Pharmacists in Precision Medicine

Course Description: As a consequence of the Human Genome project and the dramatic increase in the rate of sequencing, we are at the threshold of a new era in medicine. Advances in genetics and genomics will forever alter the “one-size-fits-all” model of medicine based on population averages. We now have the ability to tailor drug therapy to patients who are likely to respond to drugs without having significant side effects. Pharmacists have a key role to play in this revolution. This talk will give a general overview to the field of pharmacogenomics and explore the roles that pharmacists can play in realizing the full potential of precision medicine.
Learning Objectives:
  1. Describe the different types of genetic variations and the nomenclature used to describe genetic variations.
  2. Describe genetic variations in drug metabolizing enzymes, drug receptors and drug transporters that influence drug response.
  3. Describe the resources available to help clinicians understand how genetic test results should be used to optimize drug therapy.
Track: Student Programming
Content Level: Level 1: No Prior Knowledge
Speaker: Samit Shah, PhD, MBA, RPh
                     Associate Dean of Academic Affairs and Chair of Biopharmaceutical Sciences | Keck Graduate Institute School of Pharmacy

Contacts

California Society of Health-System Pharmacists
1314 H Street, Suite 200
Sacramento, CA 95814
Office: (916) 447-1033
Fax: (916) 447-2396
Email: info@cshp.org
Hours: M-F 8:00am – 5:00pm

Connect